List of Excipients in API oxaliplatin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing oxaliplatin
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Teva Parenteral Medicines Inc | OXALIPLATIN | oxaliplatin | 0703-3985 | LACTOSE MONOHYDRATE | |
Teva Parenteral Medicines Inc | OXALIPLATIN | oxaliplatin | 0703-3985 | WATER | |
Winthrop US a business of sanofi-aventis US LLC | OXALIPLATIN | oxaliplatin | 0955-1725 | WATER | |
Winthrop US a business of sanofi-aventis US LLC | OXALIPLATIN | oxaliplatin | 0955-1731 | WATER | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing oxaliplatin
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Sandoz Inc | oxaliplatin | 0781-3315 | WATER |
Sandoz Inc | oxaliplatin | 0781-9315 | WATER |
NorthStar RxLLC | oxaliplatin | 16714-727 | WATER |
Accord Healthcare Inc | oxaliplatin | 16729-332 | WATER |
Sagent Pharmaceuticals | oxaliplatin | 25021-233 | SODIUM HYDROXIDE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for oxaliplatin
Excipient focus: LACTOSE MONOHYDRATE
oxaliplatin drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | oxaliplatin | 0703-3985 |
Actavis Pharma Inc | oxaliplatin | 45963-611 |
Sun Pharmaceutical Industries Inc | oxaliplatin | 47335-176 |
Ingenus Pharmaceuticals LLC | oxaliplatin | 50742-405 |
Qilu Pharmaceutical Co Ltd | oxaliplatin | 67184-0501 |
>Company | >Ingredient | >NDC |
oxaliplatin drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | oxaliplatin | 0781-3315 |
Sandoz Inc | oxaliplatin | 0781-9315 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1725 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1731 |
NorthStar RxLLC | oxaliplatin | 16714-727 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
oxaliplatin drug variants containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Sagent Pharmaceuticals | oxaliplatin | 25021-233 |
Hospira Inc | oxaliplatin | 61703-363 |
>Company | >Ingredient | >NDC |
oxaliplatin drug variants not containing SODIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | oxaliplatin | 0703-3985 |
Sandoz Inc | oxaliplatin | 0781-3315 |
Sandoz Inc | oxaliplatin | 0781-9315 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1725 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1731 |
>Company | >Ingredient | >NDC |
Excipient focus: TARTARIC ACID
oxaliplatin drug variants containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
Sagent Pharmaceuticals | oxaliplatin | 25021-233 |
Hospira Inc | oxaliplatin | 61703-363 |
>Company | >Ingredient | >NDC |
oxaliplatin drug variants not containing TARTARIC ACID
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | oxaliplatin | 0703-3985 |
Sandoz Inc | oxaliplatin | 0781-3315 |
Sandoz Inc | oxaliplatin | 0781-9315 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1725 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1731 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
oxaliplatin drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Teva Parenteral Medicines Inc | oxaliplatin | 0703-3985 |
Sandoz Inc | oxaliplatin | 0781-3315 |
Sandoz Inc | oxaliplatin | 0781-9315 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1725 |
Winthrop US a business of sanofi-aventis US LLC | oxaliplatin | 0955-1731 |
>Company | >Ingredient | >NDC |
oxaliplatin drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | oxaliplatin | 45963-611 |
Sun Pharmaceutical Industries Inc | oxaliplatin | 47335-176 |
Qilu Pharmaceutical Co Ltd | oxaliplatin | 67184-0501 |
Gland Pharma Limited | oxaliplatin | 68083-170 |
Nextgen Pharmaceuticals LLC | oxaliplatin | 79672-825 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.